We have expertise in finding the unmet needs in a disease area and shaping the design of new diagnostics to tackle these challenges.
Through engaging with our wide networks we can overcome barriers that might prevent the new diagnostic from being widely used.
We can identify current diagnosis methods that are needed as a benchmark when measuring the accuracy of new diagnostics.
Through our expertise in systematic reviews, developers can examine what competing technologies are available on the market.
Our expertise in care pathway analysis identifies scenarios where a new diagnostic could have the best benefit on patient care.
We can perform early economic modelling to help focus future product and evidence development and inform pricing strategies.